NUVA - ニュ―ベイシブ (NuVasive Inc.)

NUVAのニュース

   Analysts Estimate NuVasive (NUVA) to Report a Decline in Earnings: What to Look Out for  2020/04/29 16:34:36 Zacks Investment Research
NuVasive (NUVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   NuVasive (NUVA) Posts Q1 Preliminary Results, Withdraws View  2020/04/16 07:36:00 Zacks Investment Research
A decline in elective surgical procedures due to coronavirus outbreak weighs on NuVasive's (NUVA) preliminary revenue results for first-quarter 2020.
   US Intraoperative Neuromonitoring Market Analysis 2020-2024, Featuring Cadwell Industries, Medtronic Plc and NuVasive Inc. - ResearchAndMarkets.com  2020/03/24 12:40:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Intraoperative Neuromonitoring Market in the US 2020-2024" report has been added to ResearchAndMarkets.com's offering. The intraoperative neuromonitoring market (IONM) in the US is poised to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period. This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers
   Here's Why You Should Hold on to NuVasive (NUVA) Stocks Now  2020/03/23 15:24:00 Zacks Investment Research
Investors continue to be optimistic about NuVasive (NUVA) on its strong segmental and international results in the fourth quarter of 2019.
   NuVasive, Inc. Announces Pricing Of Offering Of $450 Million Of 0.375% Convertible Senior Notes Due 2025  2020/02/27 07:11:00 PR Newswire
SAN DIEGO, Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering of $450,000,000 aggregate principal amount of 0.375% Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement to qualified institutional buyers…
   US Intraoperative Neuromonitoring Market Analysis 2020-2024, Featuring Cadwell Industries, Medtronic Plc and NuVasive Inc. - ResearchAndMarkets.com  2020/03/24 12:40:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Intraoperative Neuromonitoring Market in the US 2020-2024" report has been added to ResearchAndMarkets.com's offering. The intraoperative neuromonitoring market (IONM) in the US is poised to grow by USD 955.33 mn during 2020-2024, progressing at a CAGR of 10% during the forecast period. This report provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers
   Here's Why You Should Hold on to NuVasive (NUVA) Stocks Now  2020/03/23 15:24:00 Zacks Investment Research
Investors continue to be optimistic about NuVasive (NUVA) on its strong segmental and international results in the fourth quarter of 2019.
   NuVasive, Inc. Announces Pricing Of Offering Of $450 Million Of 0.375% Convertible Senior Notes Due 2025  2020/02/27 07:11:00 PR Newswire
SAN DIEGO, Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering of $450,000,000 aggregate principal amount of 0.375% Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement to qualified institutional buyers…
   NuVasive, Inc. Announces Proposed Offering Of $450 Million Of Convertible Senior Notes Due 2025  2020/02/26 13:05:00 Benzinga Feeds
SAN DIEGO , Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA ) announced today that it intends to offer (the "Offering"), subject to market and other considerations, $450,000,000 aggregate principal amount of Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). NuVasive also intends to grant to the initial purchasers of the Convertible Notes a 13-day option to purchase up to an additional $50,000,000 aggregate principal amount of the Convertible Notes. The Convertible Notes will be general unsecured obligations of NuVasive and interest will be paid semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2020. The Convertible Notes will mature on March 15, 2025, unless earlier repurchased, redeemed or converted. Prior to the close of business on the business day immediately preceding September 15, 2024 , the Convertible Notes will be convertible at the option of holders only upon the satisfaction of certain conditions and during certain periods.
   NuVasive EPS beats by $0.09, beats on revenue  2020/02/20 21:03:26 Seeking Alpha
NuVasive (NASDAQ:NUVA): Q4 Non-GAAP EPS of $0.73 beats by $0.09; GAAP EPS of $0.55 beats by $0.21. Revenue of $310.35M (+7.6% Y/Y) beats by $5.42M. Press R
   NuVasive, Inc. Announces Pricing Of Offering Of $450 Million Of 0.375% Convertible Senior Notes Due 2025  2020/02/27 07:11:00 PR Newswire
SAN DIEGO, Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA) announced today the pricing of its offering of $450,000,000 aggregate principal amount of 0.375% Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement to qualified institutional buyers…
   NuVasive, Inc. Announces Proposed Offering Of $450 Million Of Convertible Senior Notes Due 2025  2020/02/26 13:05:00 Benzinga Feeds
SAN DIEGO , Feb. 26, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA ) announced today that it intends to offer (the "Offering"), subject to market and other considerations, $450,000,000 aggregate principal amount of Convertible Senior Notes due 2025 (the "Convertible Notes") in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). NuVasive also intends to grant to the initial purchasers of the Convertible Notes a 13-day option to purchase up to an additional $50,000,000 aggregate principal amount of the Convertible Notes. The Convertible Notes will be general unsecured obligations of NuVasive and interest will be paid semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2020. The Convertible Notes will mature on March 15, 2025, unless earlier repurchased, redeemed or converted. Prior to the close of business on the business day immediately preceding September 15, 2024 , the Convertible Notes will be convertible at the option of holders only upon the satisfaction of certain conditions and during certain periods.
   NuVasive EPS beats by $0.09, beats on revenue  2020/02/20 21:03:26 Seeking Alpha
NuVasive (NASDAQ:NUVA): Q4 Non-GAAP EPS of $0.73 beats by $0.09; GAAP EPS of $0.55 beats by $0.21. Revenue of $310.35M (+7.6% Y/Y) beats by $5.42M. Press R
   Results Validating the Versatility of NuVasive's MaXcess® Retractor in Prone Single-Position XLIF® and Posterior Fixation Published in The European Spine Journal  2020/02/13 13:33:00 PR Newswire
SAN DIEGO, Feb. 13, 2020 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the results of the study, "Prone single-position extreme…
   NuVasive (NUVA) Stock Dips Despite Strong Preliminary Q4 Show  2020/01/16 15:34:54 Zacks Investment Research
NuVasive's (NUVA) revenue growth will likely beat expectations for both the fourth quarter and 2019.

calendar